-
1
-
-
84856118942
-
Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease
-
Keating GM Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease. Drugs 2012, 72:273-300.
-
(2012)
Drugs
, vol.72
, pp. 273-300
-
-
Keating, G.M.1
-
2
-
-
84857283681
-
Indacaterol: a review of its use as maintenance therapy in patients with chronic obstructive pulmonary disease
-
McKeage K Indacaterol: a review of its use as maintenance therapy in patients with chronic obstructive pulmonary disease. Drugs 2012, 72:543-563.
-
(2012)
Drugs
, vol.72
, pp. 543-563
-
-
McKeage, K.1
-
3
-
-
0037677450
-
Time course of recovery of health status following an infective exacerbation of chronic bronchitis
-
Spencer S, Jones PW Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax 2003, 58:589-593.
-
(2003)
Thorax
, vol.58
, pp. 589-593
-
-
Spencer, S.1
Jones, P.W.2
-
4
-
-
2442552129
-
Impact of preventing exacerbations on deterioration of health status in COPD
-
Spencer S, Calverley PM, Burge PS, Jones PW Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 2004, 23:698-702.
-
(2004)
Eur Respir J
, vol.23
, pp. 698-702
-
-
Spencer, S.1
Calverley, P.M.2
Burge, P.S.3
Jones, P.W.4
-
5
-
-
48949103222
-
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study
-
Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008, 178:332-338.
-
(2008)
Am J Respir Crit Care Med
, vol.178
, pp. 332-338
-
-
Celli, B.R.1
Thomas, N.E.2
Anderson, J.A.3
-
6
-
-
0036794862
-
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
-
Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002, 57:847-852.
-
(2002)
Thorax
, vol.57
, pp. 847-852
-
-
Donaldson, G.C.1
Seemungal, T.A.2
Bhowmik, A.3
Wedzicha, J.A.4
-
7
-
-
33645573320
-
COPD exacerbations. 3: Pathophysiology
-
O'Donnell DE, Parker CM COPD exacerbations. 3: Pathophysiology. Thorax 2006, 61:354-361.
-
(2006)
Thorax
, vol.61
, pp. 354-361
-
-
O'Donnell, D.E.1
Parker, C.M.2
-
8
-
-
84871253503
-
The role of bronchodilator tr.eatment in the prevention of exacerbations of COPD
-
Wedzicha JA, Decramer M, Seemungal TA The role of bronchodilator tr.eatment in the prevention of exacerbations of COPD. Eur Respir J 2012, 40:1545-1554.
-
(2012)
Eur Respir J
, vol.40
, pp. 1545-1554
-
-
Wedzicha, J.A.1
Decramer, M.2
Seemungal, T.A.3
-
9
-
-
80053090797
-
Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD
-
Buhl R, Dunn LJ, Disdier C, et al. Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD. Eur Respir J 2011, 38:797-803.
-
(2011)
Eur Respir J
, vol.38
, pp. 797-803
-
-
Buhl, R.1
Dunn, L.J.2
Disdier, C.3
-
10
-
-
77954800883
-
Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium
-
Donohue JF, Fogarty C, Lotvall J, et al. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. Am J Respir Crit Care Med 2010, 182:155-162.
-
(2010)
Am J Respir Crit Care Med
, vol.182
, pp. 155-162
-
-
Donohue, J.F.1
Fogarty, C.2
Lotvall, J.3
-
11
-
-
77957254369
-
Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium
-
Vogelmeier C, Ramos-Barbon D, Jack D, et al. Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium. Respir Res 2010, 11:135.
-
(2010)
Respir Res
, vol.11
, pp. 135
-
-
Vogelmeier, C.1
Ramos-Barbon, D.2
Jack, D.3
-
12
-
-
84888675464
-
-
Global Initiative for Obstructive Lung Disease, (accessed March 6, 2013).
-
Global Strategy for the Diagnosis, Management and Prevention of COPD (2013) Global Initiative for Obstructive Lung Disease, (accessed March 6, 2013). http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf.
-
Global Strategy for the Diagnosis, Management and Prevention of COPD (2013)
-
-
-
13
-
-
53749102775
-
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
-
Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008, 359:1543-1554.
-
(2008)
N Engl J Med
, vol.359
, pp. 1543-1554
-
-
Tashkin, D.P.1
Celli, B.2
Senn, S.3
-
14
-
-
79953166862
-
Tiotropium versus salmeterol for the prevention of exacerbations of COPD
-
Vogelmeier C, Hederer B, Glaab T, et al. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med 2011, 364:1093-1103.
-
(2011)
N Engl J Med
, vol.364
, pp. 1093-1103
-
-
Vogelmeier, C.1
Hederer, B.2
Glaab, T.3
-
17
-
-
0034105161
-
Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease
-
Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 161:1608-1613.
-
(2000)
Am J Respir Crit Care Med
, vol.161
, pp. 1608-1613
-
-
Seemungal, T.A.1
Donaldson, G.C.2
Bhowmik, A.3
Jeffries, D.J.4
Wedzicha, J.A.5
-
18
-
-
3442890263
-
Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease
-
Wilkinson TM, Donaldson GC, Hurst JR, Seemungal TA, Wedzicha JA Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 169:1298-1303.
-
(2004)
Am J Respir Crit Care Med
, vol.169
, pp. 1298-1303
-
-
Wilkinson, T.M.1
Donaldson, G.C.2
Hurst, J.R.3
Seemungal, T.A.4
Wedzicha, J.A.5
-
19
-
-
0021256105
-
The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes
-
Mahler DA, Weinberg DH, Wells CK, Feinstein AR The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984, 85:751-758.
-
(1984)
Chest
, vol.85
, pp. 751-758
-
-
Mahler, D.A.1
Weinberg, D.H.2
Wells, C.K.3
Feinstein, A.R.4
-
20
-
-
0026871146
-
A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire
-
Jones PW, Quirk FH, Baveystock CM, Littlejohns P A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992, 145:1321-1327.
-
(1992)
Am Rev Respir Dis
, vol.145
, pp. 1321-1327
-
-
Jones, P.W.1
Quirk, F.H.2
Baveystock, C.M.3
Littlejohns, P.4
-
22
-
-
0037425745
-
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
-
Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003, 361:449-456.
-
(2003)
Lancet
, vol.361
, pp. 449-456
-
-
Calverley, P.1
Pauwels, R.2
Vestbo, J.3
-
23
-
-
37849011194
-
The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide
-
Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med 2008, 177:19-26.
-
(2008)
Am J Respir Crit Care Med
, vol.177
, pp. 19-26
-
-
Wedzicha, J.A.1
Calverley, P.M.2
Seemungal, T.A.3
Hagan, G.4
Ansari, Z.5
Stockley, R.A.6
-
24
-
-
84877131237
-
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study
-
Wedzicha JA, Decramer M, Ficker JH, et al. Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study. Lancet Respir Med 2013, 1:199-209.
-
(2013)
Lancet Respir Med
, vol.1
, pp. 199-209
-
-
Wedzicha, J.A.1
Decramer, M.2
Ficker, J.H.3
-
25
-
-
77953028976
-
The short, the long, and the "ultra-long": Why duration of bronchodilator action matters in chronic obstructive pulmonary disease
-
Beeh KM, Beier J The short, the long, and the "ultra-long": Why duration of bronchodilator action matters in chronic obstructive pulmonary disease. Adv Ther 2010, 27:150-159.
-
(2010)
Adv Ther
, vol.27
, pp. 150-159
-
-
Beeh, K.M.1
Beier, J.2
-
26
-
-
84873170983
-
Muscarinic receptors on airway mesenchymal cells: novel findings for an ancient target
-
Meurs H, Dekkers BG, Maarsingh H, Halayko AJ, Zaagsma J, Gosens R Muscarinic receptors on airway mesenchymal cells: novel findings for an ancient target. Pulm Pharmacol Ther 2013, 26:145-155.
-
(2013)
Pulm Pharmacol Ther
, vol.26
, pp. 145-155
-
-
Meurs, H.1
Dekkers, B.G.2
Maarsingh, H.3
Halayko, A.J.4
Zaagsma, J.5
Gosens, R.6
-
27
-
-
26944437890
-
Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients
-
Profita M, Giorgi RD, Sala A, et al. Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients. Allergy 2005, 60:1361-1369.
-
(2005)
Allergy
, vol.60
, pp. 1361-1369
-
-
Profita, M.1
Giorgi, R.D.2
Sala, A.3
-
28
-
-
84860350181
-
Beta(2) long-acting and anticholinergic drugs control TGF-beta1-mediated neutrophilic inflammation in COPD
-
Profita M, Bonanno A, Montalbano AM, et al. Beta(2) long-acting and anticholinergic drugs control TGF-beta1-mediated neutrophilic inflammation in COPD. Biochim Biophys Acta 2012, 1822:1079-1089.
-
(2012)
Biochim Biophys Acta
, vol.1822
, pp. 1079-1089
-
-
Profita, M.1
Bonanno, A.2
Montalbano, A.M.3
-
29
-
-
79955473712
-
Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD
-
Meyer T, Reitmeir P, Brand P, et al. Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD. Respir Med 2011, 105:900-906.
-
(2011)
Respir Med
, vol.105
, pp. 900-906
-
-
Meyer, T.1
Reitmeir, P.2
Brand, P.3
-
30
-
-
11144344144
-
Effects of salmeterol on cilia and mucus in COPD and pneumonia patients
-
Piatti G, Ambrosetti U, Santus P, Allegra L Effects of salmeterol on cilia and mucus in COPD and pneumonia patients. Pharmacol Res 2005, 51:165-168.
-
(2005)
Pharmacol Res
, vol.51
, pp. 165-168
-
-
Piatti, G.1
Ambrosetti, U.2
Santus, P.3
Allegra, L.4
|